Skip to main content
Atrás
Watch Compare

AVITA Medical, Inc.

Calidad de datos: 100%
También listada como AVHHL Nasdaq
RCEL
Nasdaq Manufacturing Measuring & Analyzing Instruments
$4.38
▲ $0.28 (6.71%)
Cap. Mercado: 134.01 M
Precio
$4.38
Cap. Mercado
134.01 M
Rango del Día
$4.10 — $4.50
Rango de 52 Semanas
$3.22 — $10.29
Volumen
297,723
Apertura $4.13
Promedio 50D / 200D
$4.36
0.45% above
Promedio 50D / 200D
$4.49
2.55% below

Quick Summary

Puntos Clave

Revenue grew 50.51% annually over 5 years — strong growth
Negative free cash flow of -32.20 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 39.06%
Capital efficient — spends only 1.40% of revenue on capex

Crecimiento

Revenue Growth (5Y)
50.51%
Above sector avg (9.35%)
Revenue (1Y)11.45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net Margin-67.85%
Op. Margin-59.40%

Seguridad

Debt / Equity
N/A
Current Ratio0.67
Interest Coverage-8.50

Valoración

PE (TTM)
-2.76
Below sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -2.8 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % -67.9 -150.2
Rev Growth 5Y % 50.5 9.3
D/E — 0.3

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.03% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 11.45% Revenue Growth (3Y) 19.50%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 50.51% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 71.61 M Net Income (TTM) -48.59 M
ROE N/A ROA -79.74%
Gross Margin 82.13% Operating Margin -59.40%
Net Margin -67.85% Free Cash Flow (TTM) -32.20 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.67
Interest Coverage -8.50 Asset Turnover 1.18
Working Capital -20.46 M Tangible Book Value -11.87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.76 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1.87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -24.03%
Market Cap 134.01 M Enterprise Value 118.59 M
Per Share
EPS (Diluted TTM) -1.74 Revenue / Share 2.34
FCF / Share -1.05 OCF / Share -1.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.40% FCF Conversion 66.27%
SBC-Adj. FCF -44.43 M Growth Momentum -39.06

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 71.61 M 64.25 M 50.14 M 34.42 M 13.96 M
Net Income -48.59 M -61.85 M -35.38 M -26.67 M -14.43 M
EPS (Diluted) -1.74 -2.39 1.40 1.07 0.58
Gross Profit 58.82 M 55.16 M 42.36 M 28.38 M 12.05 M
Operating Income -42.53 M -56.59 M -42.66 M -27.51 M -14.42 M
EBITDA — — — — —
R&D Expenses 20.84 M 20.36 M 20.82 M 13.86 M 7.59 M
SG&A Expenses — — — — —
D&A 2.35 M 1.13 M 632,000.0 568,000.0 330,000.0
Interest Expense 5.00 M 5.36 M 1.14 M 16,000.0 17,000.0
Income Tax 11,000.0 54,000.0 66,000.0 36,000.0 25,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 56.39 M 79.71 M 111.64 M 98.26 M 116.02 M
Total Liabilities 73.04 M 74.97 M 61.89 M 12.97 M 11.39 M
Shareholders' Equity -16.65 M 4.50 M 49.06 M 84.74 M 104.62 M
Total Debt 0.0 42.25 M 39.81 M — —
Cash & Equivalents 10.24 M 14.05 M 22.12 M 18.16 M 55.51 M
Current Assets 35.49 M 57.00 M 104.01 M 87.46 M 92.13 M
Current Liabilities 62.68 M 20.16 M 13.20 M 10.69 M 9.15 M